![Paolo Tarantino: Interesting pan-cancer evaluation of HER2-low expression out on Annals of Oncology.](https://oncodaily.com/pub/uploads/2023/08/F4Kw9H0WwAA6UqO-1280x999.jpeg)
Photo taken from: Paolo Tarantino / Twitter
Aug 23, 2023, 23:49
Paolo Tarantino: Interesting pan-cancer evaluation of HER2-low expression out on Annals of Oncology.
Paolo Tarantino, a Research Fellow at the Dana-Farber Cancer Institute, shared the following insights on Twitter:
“Interesting pan-cancer evaluation of HER2-low expression out on Annals of Oncology (n=4701). Half of all tumors expressed HER2, with notable differences across histologies. Among patients with >1 metastatic biopsy, there was wide discordance across lesions.”
For full text click here
Source: Paolo Tarantino / Twitter
Jul 1, 2024, 03:08